English 
Deutsch COMMITTED TO QUALITY
Leipzig-based companies &
Germany's largest cannabis group
Cannabis has been legal as a stimulant in Germany since April 2024 - medicinal cannabis since 2017. The Grünhorn Group has been one of the most important players in the cannabis sector since 2020 and has a broad range of expertise.
WE ARE THE GRÜNHORN GROUP
Grünhorn is the largest German cannabis group, founded in 2020 in Leipzig. It includes, among others, the largest online mail-order pharmacy for cannabis, Schurer Pharma & Kosmetik GmbH (automated fulfillment and logistics services for pharmacies carrying cannabis), as well as canymed GmbH, a pharmaceutical wholesaler and manufacturer of medical cannabis products. Grünhorn represents strictly controlled, high-quality products and research in the cannabis sector.
Grünhorn Pharmacy
Pharmacy and Shop
Grünhorn pharmacy is one of the largest and most renowned providers of medical cannabis in Germany.
Canymed GmbH
Pharmaceutical wholesaler for medicinal cannabis
canymed GmbH is your reliable pharmaceutical wholesaler for medical cannabis,
supplying pharmacies, medical practices, and hospitals nationwide.
Schurer Pharma & Kosmetik GmbH
Automated fulfillment and logistics services for cannabis-running pharmacies
Schurer Pharma & Kosmetik GmbH (SPK) is a leading provider of automated fulfillment and logistics services for pharmacies that distribute cannabis products.
KNOWN FROM:
LATEST PRESS RELEASES
6 Monate Cannabis-Legalisierung: Erstes Fazit
Von Stefan Fritsch, CEO der Grünhorn Gruppe Als ich 2020 Grünhorn gründete, war mir bewusst,…
"There are no regulations to further advance the cannabis industry in Saxony!"
At a time when the legalization of cannabis in Germany is opening new opportunities...
SOMAÍ Launches Mint-Flavored Cannabis Extracts with Grünhorn
SOMAÍ Pharmaceuticals launches its innovative mint-flavored cannabis extracts on the German market for the first time and cooperates with...
Grünhorn CEO on G-BA decision on cannabis as a statutory health insurance benefit
"Less waiting time for patients - more trust in doctors" The Federal Joint Committee (G-BA) today...
